Xue-yan Wu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Clinical Application of Serum Tumor Abnormal Protein (TAP) in Colorectal Cancer Patients.

Clinical Application of Serum Tumor Abnormal Protein (TAP) in Colorectal Cancer Patients.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: April 30, 2015

Screening for patients with non-small cell lung cancer who could survive long term chemotherapy.

Screening for patients with non-small cell lung cancer who could survive long term chemotherapy.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: February 17, 2015

Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients.

Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: November 07, 2014

Leucogen tablets at 60 mg three times per day are safe and effective to control febrile neutropenia.

Leucogen tablets at 60 mg three times per day are safe and effective to control febrile neutropenia.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: October 24, 2014

A predictive model for evaluating responsiveness to pemetrexed treatment in patients with advanced colorectal cancer.

A predictive model for evaluating responsiveness to pemetrexed treatment in patients with advanced colorectal cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: August 02, 2014

Clinical observations on associations between the UGT1A1 genotype and severe toxicity of irinotecan.

Clinical observations on associations between the UGT1A1 genotype and severe toxicity of irinotecan.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 13, 2014

Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.

Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: January 28, 2014

Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.

Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: January 01, 2014

Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma.

Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: October 03, 2013

Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites.

Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: June 04, 2013

Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs.

Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 18, 2013

Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer.

Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 18, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026